🔥 Beyond placebo! Does AF ablation really improve quality of life? Our meta-analysis of sham-controlled RCTs shows that with AF ablation: ✅ +13.5 AFEQT points ✅ 51% lower AF recurrence ✅ Benefit beyond active-treatment controls ....and this is with SHORT follow-up and an "active treatment" control! 📖 Kakarla et al. Heart Rhythm, 2026. bit.ly/4iDdvnL @Dr_Saikiran_K @Hidehiro_1986 @DrJasonAndrade @JonathanAriya @Mel_Gunawardene @nmarrouche @melissaemm1 @Elliott_AD @peterkistler3 #AtrialFibrillation #EP #CHRD @HRSonline @thecsanz @hrs_journal

Congratulations to Dr. Hidehiro Iwakawa, Dr. Prashanthan Sanders, and the full author team on their new publication in Heart Rhythm: "Leadless pacemaker, right ventricular pacing burden, and heart failure." It's a privilege to see PaceMate data support research that shapes how clinicians care for device patients. Read the full open-access study: lnkd.in/esy7mjb9

モンベルすごいな！ちょっと感動 webshop.montbell.jp/sp/goods…

Day 3 startted with great conversation between @PrashSanders and Prof. Michel Haïssaguerre‼️ #HRX2026

Engaging discussion on social robotics and the future of health education @HRX2026

Day 2 has started!! #HRX2026

First day at #HRX for the Innovation Summit and the technology pipeline is insane 🚀. What a time to be an EP fellow! #HRX #EP #MedTech @PrashSanders @experienceHRX

Such exciting presentations at #HRX2026 in Atlanta!!

Pleased to share our new paper! The findings highlight that RV pacing burden was associated with a proportional increase ↗️ in HF risk in leadless pacemaker. #CHRD @UniofAdelaide @PrashSanders

心電図検定対策講習会 in 秋田のご案内 日時：2026年10月25日（日） 会場：市立秋田総合病院 5階講堂 午前：3級、4級トレーニングコース 午後：1級、2級トレーニングコース A：3～4級コース　残席数に余裕あり B：2～1級コース　残席わずか C：AB通しコース　残席わずか new.jhrs.or.jp/seminar/kente…

ガンダム作ってる？

Happy to have the opportunity to present two abstracts at #ESCCongress 2026!!

Do you belong at HRX Live? Dr. Prashanthan Sanders (@PrashSanders) addresses this question directly in this week's Inside HRS interview with HRX Live 2026 Executive Producer Dr. Jonathan Piccini (@JonPicciniSr) and HRS President Dr. Sana Al-Khatib (@SanaAlkhatib9). HRX began with a reputation for innovation, but today it's about something bigger. It's about bringing together the people closest to the everyday challenges in cardiovascular care and creating the conversations that lead to better solutions in the next five to ten years. Whether you're caring for patients, conducting research, developing technology, launching new ideas, or leading change in your organization, your voice belongs in the room. ▶️ With only 7 weeks until HRX Live 2026 begins, make a plan to join us in Atlanta and be part of the conversations: experiencehrx.com/hrx-live/?… HRX Live 2026 | September 18-20, 2026 | Signia by Hilton Atlanta An @HRSonline Experience HRX Live 2026 Production Team: @JonPicciniSr @PrashSanders @TinaBaykaner45 @brynndechert30 @MehakDhande @DavidDuncker @J_Hendriks1 @jasoncjacobson @RCKowalMD @Dominik_Linz Mike Lloyd, Olivier Manfredi, @drsuneet @Drdevignair @jenniferavari @ba_steinberg @EmmaSvennberg @KTamirisaMD @NTrayanova @leftbundle #Xplorers2026 #HRXLive #HRX2026 #Electrophysiology #CardiologyInnovation #MedTech #DigitalHealth #AIinHealthcare #EPeeps

In swine, PFA near the sinus node and His bundle caused distance-dependent conduction injury #Epeeps @iwanari65284818 @TAMA07120380 ahajrnls.org/4vOGRmG

A new paper published💡 We investigated the efficacy of Spot ROI, an X-ray filtering function, during AF ablation.🫀 Congratulations Nobuhiro Suzuki @76qzd2! 👏

新しい透視フィルター機能であるSpot ROIは心房細動カテーテルアブレーションにおいて手技成功率や手技時間を損なうことなく患者および術者の放射線被曝を低減した By 鈴木 暢容 @76qzd2 doi.org/10.1253/circrep.CR-2… #circ_rep #CardioX

Right Ventricular Dysfunction in Patients with Symptomatic Atrial Fibrillation: Prevalence and Functional Implications #OpenAccess @JenelleDziano @Elliott_AD heartrhythmjournal.com/artic…

What an amazing educational collaboration it was - well done @HRSonline and @thecsanz

Showcase of some work from Adelaide and the #CHRD Group to start the second day of this amazing CSP summit 🎓 🐑 Sanjai PV presenting on an ex-vivo ovine model to evaluate CSP in hypertrophied septae 🔋@JenishShroff displaying the results of the PACE-HF trial @thecsanz

Aldo Rinaldi walking us through Wise CRT at the inaugural @HRSonline and @thecsanz summit